Wright Medical Group N.V. (NASDAQ:WMGI) had its price target lowered by equities researchers at Barclays PLC from $33.00 to $30.00 in a report released on Thursday. The brokerage presently has an “overweight” rating on the medical device company’s stock. Barclays PLC’s price objective would suggest a potential upside of 14.46% from the company’s previous close.

Several other equities analysts have also commented on WMGI. BMO Capital Markets lowered their price target on shares of Wright Medical Group N.V. from $34.00 to $31.00 and set an “outperform” rating for the company in a research report on Thursday. Needham & Company LLC restated a “hold” rating on shares of Wright Medical Group N.V. in a research report on Thursday. BidaskClub upgraded shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Jefferies Group LLC restated a “buy” rating and set a $33.00 price target on shares of Wright Medical Group N.V. in a research report on Friday, August 4th. Finally, Piper Jaffray Companies restated a “buy” rating and set a $34.00 price target on shares of Wright Medical Group N.V. in a research report on Thursday, August 3rd. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Wright Medical Group N.V. currently has an average rating of “Buy” and a consensus target price of $31.50.

Wright Medical Group N.V. (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, hitting the consensus estimate of ($0.16). The business had revenue of $170.50 million during the quarter, compared to analyst estimates of $173.50 million. Wright Medical Group N.V. had a negative net margin of 36.04% and a negative return on equity of 6.22%. The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.19) earnings per share.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/wright-medical-group-n-v-wmgi-price-target-lowered-to-30-00-at-barclays-plc/1673915.html.

A number of hedge funds have recently bought and sold shares of the stock. Amalgamated Bank lifted its holdings in Wright Medical Group N.V. by 2.0% in the second quarter. Amalgamated Bank now owns 13,229 shares of the medical device company’s stock worth $364,000 after purchasing an additional 264 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Wright Medical Group N.V. by 11.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,797 shares of the medical device company’s stock worth $104,000 after purchasing an additional 396 shares during the period. Teacher Retirement System of Texas lifted its holdings in Wright Medical Group N.V. by 6.8% in the second quarter. Teacher Retirement System of Texas now owns 7,884 shares of the medical device company’s stock worth $217,000 after purchasing an additional 502 shares during the period. Legal & General Group Plc lifted its holdings in Wright Medical Group N.V. by 1.7% in the second quarter. Legal & General Group Plc now owns 36,752 shares of the medical device company’s stock worth $1,009,000 after purchasing an additional 597 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in Wright Medical Group N.V. by 9.1% in the second quarter. Prudential Financial Inc. now owns 7,678 shares of the medical device company’s stock worth $211,000 after purchasing an additional 640 shares during the period.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.